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Cell wall composition and biofilm formation 
of azoles-susceptible and -resistant Candida 
glabrata strains
Alberto Vitali1, Elisabetta Vavala2, Valeria Marzano3, Claudia Leone2,  
Massimo Castagnola3, Federica Iavarone3, Letizia Angiolella2 
1CNR-ICRM, c/o Institute of Biochemistry and Clinical Biochemistry, Catholic University, Largo F. Vito 1, Rome 
00168, Italy, 2Department of Public Health and Infectious Diseases, “Sapienza” University of Rome, P.le Aldo 
Moro 5, Rome 00161, Italy, 3Institute of Biochemistry and Clinical Biochemistry, Catholic University, Largo F. 
Vito 1, Rome 00168, Italy
In the present study, three strains of Candida glabrata have been investigated to shed light on the mechanisms 
involved in azole resistance during adherence and biofilm formation. In particular, a clinical isolate, susceptible to 
azole-based drugs, DSY562 and two different resistant mutagenic strains deriving from DSY562, SFY114 and 
SFY115, have been analysed with different approaches for their cell wall composition and properties. A proteomic 
analysis revealed that the expression of six cell wall-related proteins and biofilm formation varied between the 
strains. The SFY114 and SFY115 strains resulted to be less hydrophobic than the susceptible parental counterpart 
DSY562, on the other hand they showed a higher amount in total cell wall polysaccharides fraction in the total 
cell wall. Accordingly to the results obtained from the hydrophobicity and adherence assays, in the resistant strain 
SFY115 the biofilm formation decreased compared to the parental strain DSY562. Finally, the total glucose amount 
in resistant SFY115 was about halved in comparison to other strains. Taken together all these data suggest that 
azole drugs may affect the cell wall composition of C. glabrata, in relation to the different pathogenic behaviours.
Keywords: Proteomic, Cell wall, Drug-resistance, Adherence, Biofilm, Hydrophobicity, Polysaccharides, Candida glabrata
Introduction
Compared to other Candida species, Candida glabrata has 
recently emerged as the second most common cause in 
human of mucosal and disseminated candidiasis.1 C. gla-
brata is a haploid yeast accounting for approximately the 
15% of all Candida infections worldwide, particularly the 
bloodstream ones,2,3 in which the formation of hyphae or 
pseudohyphae during colonization or tissue infection has 
not been observed. Several studies suggest that nosoco-
mial acquisition of C. glabrata is quite common and may 
be due to exogenous factors. Moreover, two major risk 
factors associated with C. glabrata colonization are the 
prolonged duration of hospitalization and previous anti-
microbial treatments.4 Additionally, the haploid nature of 
C. glabrata genome makes the pathogen especially well 
suited for acquiring and expressing multi drug resistance 
(MDR) traits in the presence of drug pressure5 rendering 
its eradication particularly hard to achieve. Recent surveil-
lance data have revealed an increase of C. glabrata clinical 
isolates that display resistance to not only azoles, but also 
to the echinocandin-class of antifungals drugs inhibiting 
cell wall biosynthesis.6 Comparably to other pathogenic 
Candida species, the cell wall of Candida glabrata is the 
point of contact between host and fungus. The cell wall 
components mediate tissue adhesion and invasion, give 
protection against host defence reactions, trigger the host 
immune response and may also confer resistance to anti-
fungal drugs.7,8 Common to many other fungi, the central 
core of their cell wall is a branched β-(1-3), β-(1-6) glu-
can connected to chitin, acting as a linker to outer cell 
wall mannoprotein. The outer glycoprotein layer of the 
fungal cell wall plays a major role in host recognition.9 
The primary event in Candida infection is the adhesion to 
host surfaces, which is required for initial colonization and 
subsequent biofilm formation. The adherence of micro-or-
ganisms to surfaces involves numerous factors such as 
the expression of specific cell surface glycoproteins.10 
Yeast cell surface hydrophobicity (CSH) is involved 
in the adherence process of yeasts, for the presence of 
hydrophobic proteins embedded in the cell wall matrix11,12 
beneath an outer fibrillary layer. In C. glabrata, these cell–
cell adhesive interactions are mediated by a set of cell 
surface adhesins encoded by the EPA (epithelial adhesin) 
gene family. Several of the EPA proteins are significant 
for adherence and virulence.13 Indeed, C. glabrata EPA1 
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is up-regulated during early stages of adhesion to human 
epithelial cells,14,15 whereas EPA6 is expressed during bio-
film development.16,17 C. glabrata lacks the yeast-to-hy-
phae transition, a crucial phenomenon during C. albicans 
biofilm development as this morphogenesis is required to 
create a thick three-dimensional structure.18 In spite of this, 
C. glabrata is able to form biofilms with a typical archi-
tecture, characterized by a thick network of yeast cells 
embedded in the extracellular material19 rich in proteins 
and carbohydrates as reported by Silva et al.20.
In the present study, we investigate from different 
points of view the differences between drug-resistant and 
drug-susceptible strains of C. glabrata, analysing the pol-
ysaccharide composition of the cell wall and its protein 
content through a proteomic approach, and measuring the 
cell surface hydrophobicity, the adherence and the biofilm 
formation.
Materials and methods
Chemicals
All reagents were purchased from Sigma-Aldrich (Milan, 
Italy) unless otherwise stated. Solution and chromato-
graphic eluent were made with deionized water with a 
specific resistance of 18.2 MΩ·cm (Water Purification 
System, P-nix PowerIScholar;Human Corporation, Seul, 
Korea). Acetonitrile (ACN) and Formic Acid (FA) were 
obtained from Merck KGaA (Darmstadt, Germany).
Strains and growth conditions
Three strains of Candida glabrata have been object of 
this study: DSY562, a clinical isolate, susceptible to 
azoles (DSY562 Oropharynx; 8, 0.125, 0.125 μg/ml MIC 
of Fluconazole, Itraconazole and Ketoconazole, respec-
tively) and two mutagenic strains deriving from the paren-
tal strain DSY562 resistant to azoles: SFY114 (>64 μg/
ml) (DSY562 pdr1D-PDR1) and SFY115 (DSY562 
pdr1D-L280F).21 Each strain was routinely maintained 
on Sabouraud Dextrose Agar (2%) medium (SDA; Difco, 
Detroit, MI; USA) at 28 °C.
Cell wall protein preparation
For all the experimental purposes, the strains were grown 
on yeast nitrogen base medium (Y.N.B.; Difco) supple-
mented with 0.1% glucose, at 28 °C. Cell wall prepa-
rations were carried out as previously described.22 Cell 
walls were suspended in 0.05 M Tris-HCl pH 6.8 buffer 
containing 50 mM Dithiothreitol (DTT), 1 mM Phenyl-
methyl sulfonyl-fluoride (PMSF) and 20 Units/ml of a 
purified β-1,3 Glucanase (Zymolyase 100T; Seikagaku 
Kogyo Co. Ltd, Tokyo, Japan). After incubation at 37 °C, 
the solution containing the digested walls was centrifuged 
and the supernatant, containing the released proteins, was 
precipitated by adding 4 volumes of cold absolute Ethanol 
(4 °C, overnight). Proteins obtained by this procedure will 
be referred to as CWPs (cell wall proteins). Two biological 
replicates were carried out for each sample.
Two-dimensional gel electrophoresis (2-DE) 
and image analysis
CWPs pellets were dissolved in rehydration buffer contain-
ing 6 M Urea, 2 M Thiourea, 4% CHAPS, 15 mM DTT, 
0.2% Bio-Lyte 3/10 Ampholyte (Bio-Rad Laboratories, 
Hercules, CA, USA) and the protein concentration was 
detected using a 2-D Quant kit (Amersham Biosciences, 
Uppsala, Sweden). For the first dimension, 100 μg of 
total proteins, with trace amounts of bromophenol blue, 
were loaded onto pH 3–10 nonlinear 11 cm gel IPG strips 
(Ready Strip; Bio-Rad) and isoelectric focusing was per-
formed using a Protean IEF Cell (Bio-Rad) running the 
samples at 20 °C a total final voltage of 35kVh. Isoelectric 
focused strip gels were incubated for 15 min in equilibra-
tion solution (6 M Urea, 50 mMTris-HCl pH 8.8, 30% 
Glycerol, 2% Sodium dodecyl sulphate (SDS), 0.002% 
Bromophenol blue) with 1% dithiothreitol (DTT) and 
then for 15 min with 4% Iodoacetamide (IAA). The sec-
ond-dimension separation was performed on 12% Bis-
Tris Criterion-XT precast gels (11 cm; Bio-Rad) using a 
Criterion Cell apparatus (Bio-Rad). 2-D gels were stained 
with colloidal Coomassie Blue stain23 and scanned with a 
GS-800 Calibrated Densitometer (Bio-Rad). The images 
were analysed using PDQuest software (version 7.0.1; 
Bio-Rad) and subsequently three high-quality gels for each 
strain were chosen, being the choice based on protein spot 
resolution and number, to allow experimental statistical 
comparison. The CWPs 2-DE gels were compared using 
the DSY562 strain as a control. Following to automatic 
background subtraction, spot detection and spot filtering, 
a reference gel was selected from one of the experimental 
gels. Then, unmatched protein spots of the remaining gels 
were manually added to this reference gel to create the 
master gel, a virtual image comprehensive of all matched 
spots derived from all analysed samples. The matching 
of spots between gels was manually reviewed and optical 
density of protein spots was quantified, in order to perform 
a differential analysis of protein patterns. The gels were 
collected in three separated groups (DSY562, SFY114 and 
SFY115), and for each detected spot the average opti-
cal density value ± standard deviation in each group was 
determined. The ratio of the mean normalized spot inten-
sity of resistant vs. susceptible samples was calculated for 
the spots identified in the replicates of strains gel deriving 
from each yeast. Only spots with a p < 0.05, according to 
the T Student’s test, were accepted.
Protein identification
Spots of interest were manually excised from 2-DE gels and 
destained with 25 mM ammonium bicarbonate (NH4HCO3)/
ACN 1:1 (v/v), dehydrated with 100% ACN, reduced with 
10 mM DTT in 25 mM NH4HCO3 and alkylated with 55 mM 
IAA in 25 mM NH4HCO3. After complete dehydration, a 
solution of 0.01 μg/μL porcine methylated Trypsin (Promega, 
Madison, WI, USA) in 25 mM NH4HCO3 was added, and 
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proteins were digested at 37 °C overnight. The reaction was 
stopped by adding trifluoroacetic acid (TFA) at a final con-
centration of 0.1%. The supernatants containing tryptic pep-
tides were collected along with peptide fragments extracted 
from the spot gel with 100% ACN/0.1% TFA in water 3:2 
(v/v). Tryptic peptides were evaporated, then dissolved in 
0.1% FA and analysed by liquid chromatography–electro-
spray ionization tandem mass spectrometry (LC-ESI-MS/
MS) on an Ultimate 3000 Micro HPLC apparatus (Dionex, 
Sunnyvale, CA, USA) equipped with a FLM-3000-Flow 
manager module, directly coupled to a LTQ Orbitrap XL 
hybrid FT mass spectrometer (Thermo Fisher Scientific, 
Waltham, MA, USA). Reverse-phase chromatography was 
performed on a Discovery Bio Wide Pore C18 column (3 μm 
particle diameter; column dimension 1 mm id × 10 cm; 
Supelco Park, Bellefonte, PA, USA) at a flow rate of 80 μL/
min, using the following eluents: (A) 0.056% (v/v) aqueous 
FA and (B) acetonitrile: water, 80:20 with 0.05% (v/v) aque-
ous FA. The applied gradient was linear from 0 to 50% of 
solvent B in 60 min. The LTQ-Orbitrap mass spectrometer 
was operated in a data-dependent mode in which each full 
mass spectrometric (MS) scan (mass range 300–2000 Da, 
60,000 resolving power) was followed by data dependent 
fragmentation experiments (MS/MS) of the three most abun-
dant multiple-charged precursor ions acquired in the linear 
trap quadrupole via by collision-induced dissociation using 
a normalized collision energy of 35%. Tandem mass spectra 
were analysed by Proteome Discoverer program (version 
1.4.1; Thermo Fisher Scientific), using the embedded ion 
accounting algorithm (Sequest HT) as search engine against 
UniProt KB Protein Knowledgebase (release 2014_02 of 19 
February 14 containing 542503 sequence entries; taxonomi-
cal restriction: Candida glabrata, 5195 sequence entries). The 
search parameters were 10 ppm tolerance for precursor ions 
and 0.6 Da for product ions, 1 missed cleavage and carba-
mydomethylation of cysteine as fixed modification, oxidation 
of methionine as variable modification and on a decoy data-
base search calculated false discovery rate (FDR) under 5%.
Adherence assay and biofilm formation
Cells were grown for 24 h at 28 °C in a 1% yeast extract, 
2% peptone, 2% dextrose (YPD) broth, washed twice with 
sterile PBS (10 mM phosphate buffer, 2.7 mM potassium 
chloride, 137 mM sodium chloride, pH 7.4) and then sus-
pended in RPMI 1640 supplemented with morpholine 
propane sulfonic acid (MOPS) at1.5 × 103cells/ml. After 
incubation for 3 h at 37 °C in six-well polystyrene plates 
(Corning Incorporated, Corning, NY) followed by exten-
sive washing, 1 ml of Sabouraud dextrose agar (SDA) was 
poured into each well and let solidify. After incubation for 
24 h at 37 °C, colonies were counted and the results were 
expressed as a percentage of the inoculum. The inoculum 
size for each cell suspension was confirmed by plating 
aliquots of the culture directly in SDA plates. For biofilm 
formation, cells grown as above were seeded at a density 
of 1 × 106 cells/ml in pre-sterilized, polystyrene, flat bottom 
six-well microtiter plates (Corning, N.Y) and incubated for 
48 h at 37 °C. After biofilm formation, the medium was 
aspirated and non-adherent cells were removed, carefully 
washing the biofilms three times with sterile PBS. A semi 
quantitative measurement of metabolic activity of biofilm 
formation was made by CV assay,24 the biofilms were fixed 
with 99% v/v methanol for 15 min, and then 0.02% (v/v) 
CV was added for 20 min. Biofilms were washed and 33% 
(v/v) acetic acid was added again for 30 min. The CV 
released was measured at 590 nm. Biofilm cultures were 
grown in triplicate and each assay performed three times.
Hydrophobicity assay
Hydrophobicity levels of the cell surface were determined 
by a two-phase system.7 The cells were grown on SDA 
for 24 h at 28 °C. Liquid YEPD medium (2% Peptone, 
1% Yeast extract and 2% glucose), was inoculated with 
cells at a starting OD600 of 0.08 and subsequently cul-
tured at 30 °C. Cells were harvested during exponential 
growth (OD600 of 2) or after 24 h, when all glucose had 
been consumed. The cells were washed with sterile saline 
buffer and afterwards suspended at a concentration of 
2 × 106 cells/ml in sodium phosphate buffer 0.05 M, pH 
7.2. Then, 3 ml of the cell suspension were transferred 
into a glass tube containing 500 μl octane and mixed for 
1 min by moderate vortexing. After the separation of the 
phases, the aqueous phase was carefully transferred to a 
cuvette and the OD600 was measured. Each value is the 
average of three independent biological replicas for each 
strain, with five measurements per individual cell culture.
Determination of dry weight and 
polysaccharide content
For dry weight determination, cells grown for 24 h at 
30 °C under shaking were used. Each culture (50 ml) was 
filtered through 0.45-μm membrane filters (Millipore). 
Filters were washed with 50 ml of distilled water and dried 
for 12 h at 80 °C, and the dry weight was calculated for 
each strain. Each assay was performed in triplicate. For 
determination of alkali-acid-soluble and insoluble cell wall 
components, the strains DSY562, SFY114 and SFY115 
were grown in YPD broth for 24 h at 28 °C. The cells 
were hydrolyzed as described by Fleet and Manners.25,26  
An aliquot of the cells were treated with 0.5 M acetic 
acid for 3 h at 60 °C and centrifuged. Then, the resultant 
pellet was treated with 0.5 M NaOH for 6 h at 90 °C. The 
insoluble residue was treated with 20 U/ml of a purified 
ß-1, 3 Glucanase (Zymolyase 100T) overnight at 37 °C. 
Carbohydrates were assayed by the method described by 
Dubois et al. 27
Statistical analysis
All experiments were performed in triplicates and values 
presented are the mean with standard deviation, obtained 
from three different observations. Student’s t-test was 
used for statistical analysis and a value of p < 0.05 was 
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SFY114 and SFY115 more evidently in the second strain. 
Likewise, the superoxide dismutase Q6FWL5 (ssp7401) 
was down-regulated in both resistant strains with major 
effect in SFY115. The Lysophospholipase 1 Q6FTS0 
(ssp2702) was down-regulated in SFY115 while it resulted 
up-regulated in SFY114 (Fig. 2).
Effects of drug-resistance on adherence, 
hydrophobicity and biofilm production
Adherence to host surfaces is a required feature for initial 
colonization and for biofilm formation in yeasts. In order 
to understand if the drug resistance could affect the adher-
ences, hydrophobicity and biofilm formation, we exam-
ined in the susceptible (DSY562) and resistant (SFY114, 
SFY115) strains of C. glabrata the adherence ability on 
plastic surface, the hydrophobicity and biofilm formation 
by a semi quantitative Cristal violet assay (CVA). As 
shown in Fig. 3A, the three strains behaved differently in 
their ability to adhere; in particular, SFY115 strain showed 
a reduction in adherence of about the 60% compared to 
the other two strains. It was reasonable to expect that the 
distribution and composition of the molecules involved 
in the adhesion events were differently modulated among 
the three strains. Indeed, CSH values obtained by a two-
phase system showed that the resistant strains SFY114 
and SFY115 resulted to be less hydrophobic than the sus-
ceptible parental counterpart DSY562, with a reduction 
of about 40 and 50%, respectively (Fig. 3A). The results 
obtained clearly demonstrate that the drug resistance fea-
ture reflects a marked difference in the cell wall compo-
sition of these strains. In particular, the resistant strain 
SFY115 showed an evident decrease in hydrophobicity 
when compared to the parental strain DSY562, suggesting 
a general down regulation of many proteins of the cell wall 
deputed to adhesion. Fig. 3B shows the results of biofilm 
formation in resistant strains (SFY114, SFY115) compared 
to the sensitive strain DSY562, at 24 and 48 h in CV assay. 
In the first 24 h of biofilm formation, SFY115 exhibited 
an increase of about 50% of biofilm formation in com-
parison to the sensitive strain DSY562 and the resistant 
strain SFY114. Moreover, after 48 h of biofilm formation 
when the biofilm was mature, a marked low increase in 
biofilm formation was accounted for SFY115, while for 
the strains DSY562 and SFY114 the biofilm growth was 
almost triplicated, in fairly agreement with the adherence 
data (Fig. 3A).
Content of polysaccharides
The fungal cell wall is a plastic and dynamic structure 
that constantly changes in response to environmental 
signals, with a number of highly efficient compensatory 
mechanisms. Therefore, we analysed the cells of the 
three strains in search for any variation in the major cell 
wall components. As shown in Table 2, the total glucose 
amount in DSY562 and SFY114 strains is similar, while 
a halved quantity can be observed in SFY115. Regarding 
considered statistically significant (*) and p < 0.001 as 
highly significant (**) for comparisons.28
Results
Proteomic analysis
To gain insight into the mechanisms involved in azole 
resistance, we analysed different aspects of the cell wall 
composition of three selected strains of Candida glabrata: 
DSY562, an azole susceptible clinical isolate; SFY114 and 
SFY115, two different resistant mutagenic strains deriving 
from DSY562. Cell wall preparations of the three strains 
were analysed by means of 2-DE mapping in order to 
investigate the differential expression of CWPs between 
azoles-susceptible and -resistant yeasts. Equal amounts of 
each CWPs extract were submitted to 2-DE electrophore-
sis; multiple gels were run for each sample and one rep-
resentative gel deriving from the control strain DSY562, 
was used as a reference 2-DE map (Fig. 1). Image and 
statistical analysis were performed by PDQuest software 
and analysed as reported in experimental section. Six 
proteins showed statistically significant variability in the 
expression pattern between the samples (Fig. 1 and Table 
1). The corresponding spots were excised from 2-DE gels, 
digested with trypsin and subjected to mass spectrometry 
analysis. LC-ESI-MS/MS investigation lead to their iden-
tification and Gene Ontology (GO) classification as listed 
in Table 1. The cell wall proteins Q6FTZ7 (ssp7502: being 
ssp the standard spot number as assigned by the PDQuest 
software) and Q6FUQ9 (ssp7802) resulted up-regulated 
in the SFY114 strain, while they were down-regulated in 
the SFY115 strain in a similar fashion, as shown in Fig. 
2. Q6FTS0 (ssp2702), a protein similar to Saccharomyces 
cerevisiae BGL2 (Soluble cell wall protein 9; Glucan 1, 
3-beta-glucosidase), was up-regulated in SFY115 while in 
SFY114 was at control level. The phosphoglycerate-mu-
tase Q6FUX8 (ssp6404) appeared down-regulated both in 
Figure 1 2-DE gel of DSY562 strain, used as a reference for all 
the three kind of samples. CWPs were loaded on immobilized 
non-linear pH gradients strips in the horizontal dimension 
followed by sodium dodecyl sulphate–polyacrylamide gelsin 
the vertical dimension. The gels were visualized by colloidal 
Coomassie staining. Marked protein spots were differentially 
expressed in azoles-resistant and -susceptible C. glabrata 
strains. SSP, Standard Spot number, is the number assigned 
by PDQuest software to each master gel spot.
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second most common cause of candidiasis after Candida 
albicans. Moreover, C. glabrata intrinsically displays 
reduced susceptibility to azole drugs and shows a high 
propensity to developed secondary resistance.6 In the pres-
ent study, we have carried out a comprehensive analysis in 
order to identify molecular characteristics and differences 
in C. glabrata cells of the cell wall yeast associated with 
azole-based drugs resistance. To get insights into the com-
plex mechanism of the acquired resistance, we selected 
one azole-sensitive and two azole-resistant yeast strains.
The protein profile of the resistant strains was compared 
to the sensitive counterpart by a 2-DE/mass spectrometry 
combined proteomic approach supported by a database 
search to identify the differentially expressed proteins. This 
analysis highlighted the modulation of six proteins between 
the resistant and sensitive conditions; four of these proteins 
(Q6FTS0, Q8TG0, Q6FTZ7, Q6FUQ9) are termed by GO 
cellular compartment classification as cell wall secreted, 
extracellular and fungal-type cell wall. Q6FTZ7 (gene 
name: CAGL0F07579 g) has been previously described as 
the total cell wall polysaccharides content, the two drug- 
resistant strains show a similar behaviour when compared 
to the parental strain. However, there is a marked relative 
decrease of the cell wall alkali-acid insoluble constituents, 
which is mostly due to β 1, 3-glucan. In particular, the con-
tent of the alkali-acid insoluble material per equal cell wall 
preparation amount of the SFY114 strain was less than 
half that of the parental, drug-susceptible strain (Table 2).
It was interesting to note that relative amounts of glucose 
and alkali-acid insoluble material (β 1, 3-glucan) is inverted 
in the two resistant strains, while the total polysaccharide 
amount results is similar. From a functional point of view, 
the two resistant strains behave differently, being SFY114 
more adherent than SFY115. This aspect suggests that both 
strains lower the amount of the β 1,3-glucan and its precursor 
(glucose) as compensatory cell wall mechanism.
Discussion
Candida glabrata is commensal yeast that has emerged as 
an important opportunistic pathogen and has become the 
Table 1 Summary of spots obtained from DSY562, SFY114 and SFY115 2DE and mass spectrometry analysis
Notes:  Regulation of relative intensities was calculated from statistical analysis performed with PDQuest software; symbols stay for: +, con-
trol; ++ up-regulated, +++ moderately up-regulated, - down-regulated, -- moderately down-regulated, --- strongly down-regulated. In the 
table are listed the following parameters: alphanumeric unique protein sequence identifier (Accession) provided by UniProtKB/Swiss-Prot 
protein Knowledgebase, Protein name (and Gene Ontology molecular function), Gene name, protein identification’s SEQUEST HT Score, 
percentage of protein sequence covered by identified peptides (Coverage), theoretical Molecular Weight (in kiloDalton) and pI.
# spot
Regulation
Accession-
number
Proteinname 
(molecularfunc-
tion) Gene name Score Coverage (%)
MW 
[kDa] pIDSY562 SFY114 SFY115
ssp2702 + + ++ Q6FTS0 Similar to 
uniprot|P15703 
Saccharomy-
ces cerevisiae 
YGR282c BGL2 
(hydrolase activ-
ity, hydrolyzing 
O-glycosyl 
compounds)
CAGL0G00220g 21.95 26.62 33.7 4.6
ssp3902 + +++ - Q8TG07 Lysophos-
pholipase 1 
(lysophospholi-
paseactivity)
PLB1 90.56 20.49 71.6 4.86
ssp6404 + - -- Q6FUX8 Strain CBS138 
chromosome 
E complete 
sequence (phos-
phoglyceratemu-
tase activity)
CAGL0E06358g 319.63 19.84 27.6 7.06
ssp7401 + -- --- Q6FWL5 Superoxidedis-
mutase [Cu-Zn] 
(metal ionbind-
ing; superoxide-
dismutaseac-
tivity)
SOD1 99.15 87.66 15.7 6.27
ssp7502 + ++ -- Q6FTZ7 Strain CBS138 
chromosome 
F complete 
sequence (struc-
tural constituent 
of cell wall)
CAGL0F07579g 1048.88 40.09 20.7 7.4
ssp7802 + ++ -- Q6FUQ9 Strain CBS138 
chromosome 
F complete 
sequence (struc-
tural constituent 
of cell wall)
CAGL0F01463g 80.37 9.05 21.4 7.4
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and negative character to the protein. Therefore, Q6FTZ7 
(CAGL0F07579g) and Q6FUQ9 (CAGL0F01463g) were 
identified by LC-MS/MS in C. glabrata biofilms as struc-
tural mannoprotein and mannoprotein of the Srp1p/Tip1p 
family, respectively.31 The up-regulation of these proteins in 
SFY114 may be correlated with the higher adherence pro-
pensity of this strain compared to the SFY115, where the 
same proteins were down-regulated. Lysophopspholypase 
1 (Q8TG07, PLB1), up-regulated in SFY114 and down- 
regulated in SFY115, was also identified as C. glabrata GPI 
CWP by GPI algorithm and belongs to the Phospholipase B 
class of well-known plasma-membrane-localized fungal GPI 
proteins.29 This protein was also described as a component of 
the cell wall of C. albicans.32 The expression of phospholi-
pase B1 mRNA and protein (both of secreted and intracellular 
forms) were found to be higher in fluconazole resistant strains 
than in susceptible strains of C. albicans.33 Phospholipase 
B catalyzes the release of fatty acids from lysophospholip-
ids and may as well contribute to pathogenicity by helping 
fungi in damaging and traversing host cell membranes, two 
processes which likely increase the rapidity of disseminated 
infection. PLB activity is an important determinant of the vir-
ulence of several fungi, including C. albicans, Cryptococcus 
neoformans and Aspergillus fumigates.34
Two out of six differentially expressed proteins 
are described by Gene Ontology as cytosolic ones: the 
glycosyl-phosphatidylinositol-modified (GPI) protein and it 
is one of the main components of C. glabrata cell wall in 
an ‘in silico’ and proteomic investigation.29 Moreover, two 
other proteins, Q6FUQ9 (CAGL0F01463g) and Q6FTS0 
(CAGL0G00220g) were also described by Weig et coworkers 
as a GPI structural cell wall protein and a covalent bound CWP 
belonging to glycoside hydrolase family17, respectively. In 
the abundant family of S. cerevisiae Q6FTZ7 is homologous 
to Cwp1p and Q6FUQ9 GPI CWPs to Srp1p/Tip1p; whereas 
Q6FTS0 is homologous to Bgl2p from S. cerevisiae. The 
Cwp1p and Bgl2p transcripts were described as up-regulated 
after a transient cell wall damage.30 Identification of CWPs 
by gel-based methods is difficult, because CWPs are heavily 
glycosylated and often also phosphorylated, therefore, they 
give rise to different forms of the same protein. The evidence 
that spots 7502 and 7802 have apparent higher molecular 
masses (80 and 30 kDa, respectively) than the theoretical 
molecular masses of the corresponding identified proteins 
(Q6FTZ7 and Q6FUQ9, respectively), as observed in the 
gel, may be due to the treatment utilized to isolate cell wall 
proteins: Zymolyase cuts the glycosidic links among cell wall 
sugars but is not able to cut the mannose-proteins linkages 
that give rise to different glycosylated forms of the same 
protein, resulting different apparent isoforms. The remaining 
O-linked carbohydrate side-chains may indeed, contain man-
nosyl-phosphate groups, which confer both higher masses 
Figure 2 Histogram plot of statistical protein spot differences between the DSY562, SFY114 and SFY115 yeast strains. Polypeptide 
quantities were calculated in parts per million of the total integrated spot optical density (y-axis). Average and standard deviation 
(as error bars) of each differentially regulated protein spot are shown.
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species, and, in multiple clinical isolates, azole-induced 
ROS production was suggest as a mechanism of action 
of these drugs.39 These data suggest a role for ROS pro-
duction and enhanced susceptibility to oxidative damage 
in the cells. A lower presence of SOD1 in the cell wall 
of SFY114 and SFY115 isolates could be explained by 
a greater displacement in the cytoplasm of SOD1 total 
fungus pool. These results are in agreement with previ-
ous data.40 stating how the resistance to fluconazole has a 
protective role against ROS in C. albicans.
Antimicrobial drugs may be included as possible agents 
that affect the adhesion process altering the microbial 
cell surface involved in the interaction.41 Castano et al.14 
reported that the adherence of C. glabrata to human epi-
thelial cells is mediated by multiple mechanisms, including 
electrostatic, hydrophobic and specific adhesin-receptor 
mediated interactions. In C. glabrata, this interaction 
depends on the expression of EPA, which encodes a lectin 
Phosphoglycerate mutase Q6FUX8 and the Superoxide 
dismutase Q6FWL5 (ssp6404 and 7401, respectively; 
down-regulated in both resistant strains); however these 
two proteins have already been described as present in cell 
wall of other fungi.35–37 Both proteins were also identified 
as modulated azole-resistant C. glabrata cytosolic pro-
teins.38 Interestingly, in the same study, Phosphoglycerate 
mutase was identified as down-expressed in the mutant 
azole-resistant yeast culture compared to susceptible wild-
type isolate, suggesting a corresponding decrease in the 
metabolic rate and down-regulation of the carbohydrate 
metabolism.
Superoxide dismutase [Cu–Zn] was reported by 
Loureiro38 as up-regulated cytosolic protein in azole-re-
sistant mutant strain; while in our study a down-expression 
of CW SOD occurred in both resistant strains. Miconazole 
and Fluconazole are known to induce the production of 
endogenous reactive oxygen species (ROS) in Candida 
Figure 3 Adherence, hydrophobicity and biofilm formation of C. glabrata strains DSY562, SFY114 and SFY115. (A) Percentage 
of plastic adherent cells and cell surface hydrophobicity values measured with a two phase system. (B) Istograms of Cristal 
violet assay (CVA) values after 24 and 48 h of biofilm formation. Mean values of % hydrophobicity and adherence ± SD and 
biofilm formation ± SD of three independent experiments are shown; (*) p < 0.05 is considered statistically significant and (**) 
p < 0.001 highly significant.
Table 2 Cell wall composition of drug-susceptible and resistant C. glabrata strains
aExpressed as a percentage of cell dry weight and measured by the method of Dubois et al.
bExpressed as a percentage of cell dry weight.
cExpressed as a percentage of alkali–acid-insoluble cell wall material/milligram of cell wall dry weight.
Strains % Glucosea % Cell wallb % Alkali-acid insolublec
DSY562 54.5 ± 4.95 10.4 ± 0.56 32 ± 2.12
SFY114 54.4 ± 2.12 13.1 ± 1.55 6.6 ± 0.28
SFY115 27.2 ± 1.69 8.7 ± 0.91 25 ± 0.70
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though this modulation is not same in the two resistant 
strains SF114 and SF115. Nonetheless, further studies are 
needed to validate this hypothesis and to understand the 
relationship between drug resistance and modification of 
cell wall of the human opportunistic pathogen C. glabrata.
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